Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2024 / Sep / How Long-Term Lifestyle Changes Impact Children's Serum Metabolites
Omics Metabolomics & Lipidomics Clinical Chromatography Liquid Chromatography Mass Spectrometry

How Long-Term Lifestyle Changes Impact Children's Serum Metabolites

Eight-year diet and exercise intervention in children leads to lasting effects on metabolic pathways, improving cardiometabolic health

09/25/2024 2 min read

Share

Credit: Adobe Stock

A study spanning eight years examined a range of serum metabolites in children, demonstrating that sustained lifestyle interventions can influence the body's metabolic profile, particularly in lipid metabolism.

The researchers employed non-targeted liquid chromatography-mass spectrometry (LC-MS) metabolomics analysis to measure the effects of a combined diet and physical activity intervention on 315 serum metabolites in children. The study, part of the "Physical Activity and Nutrition in Children" (PANIC) trial, tracled 504 children aged 6–9 years from Finland over eight years.

The intervention program consisted of regular counseling sessions focusing on improving the children's diet and physical activity levels. Key dietary goals included reducing the consumption of high-fat dairy and meat products, increasing intake of unsaturated fats through vegetable oils, and encouraging the consumption of vegetables, fruits, and whole grains. Participants were also advised to reduce sugar and salt intake while increasing overall physical activity and decreasing sedentary time. Children in the intervention group were also encouraged to join after-school exercise clubs to further boost their physical activity levels.

Key findings from the study revealed that 17 metabolites were significantly impacted by the intervention over the eight-year period, including fatty amides, acylcarnitines, and phospholipids. Notably, the intervention led to sustained elevations in levels of fatty amides, such as palmitic amide, linoleamide, and oleamide, which are bioactive lipids known to regulate inflammation and sleep.

The study also observed changes in microbiota-derived metabolites, including hippuric acid and indolepropionic acid, both of which were linked to improved glucose metabolism. Elevated levels of these metabolites in the intervention group suggest that the dietary improvements positively influenced gut health and metabolic function over the long term.

The research also demonstrated effects on purine metabolism, noting significant changes in the levels of guanosine, inosine, and xanthine metabolites involved in energy homeostasis and associated with physical activity.

“Our research provides compelling evidence that early and sustained lifestyle changes can have a profound impact on a child’s health trajectory,” said Timo Lakka, the lead researcher of the study, in a press release. 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.